BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

PSX Closing Bell: Red by a Whisker

K-Electric not involved in shareholder arbitration

Zarea partners with Chinese Agri-Tech for $2m collaboration

Name	Price/Vol	%Chg/NChg
KSE100	187,033.27 703.36M	-0.84% -1588.52
ALLSHR	112,355.64 1,322.41M	-0.80% -909.82
KSE30	57,253.65 170.47M	-0.83% -477.72
KMI30	264,339.24 259.66M	-0.84% -2232.30
KMIALLSHR	72,280.61 865.86M	-0.69% -504.24
BKTi	53,720.25 43.65M	-1.13% -611.48
OGTi	39,202.65 25.16M	0.13% 50.73

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	89,710.00	90,600.00 87,875.00	45.00 0.05%
BRENT CRUDE	65.03	65.41 63.61	0.11 0.17%
RICHARDS BAY COAL MONTHLY	86.75	0.00 0.00	-1.85 -2.09%
ROTTERDAM COAL MONTHLY	98.75	98.75 98.50	0.90 0.92%
USD RBD PALM OLEIN	1,027.50	1,027.50 1,027.50	0.00 0.00%
CRUDE OIL - WTI	60.50	60.89 59.22	0.14 0.23%
SUGAR #11 WORLD	14.79	14.90 14.66	0.07 0.48%